Hoshi Iryo-Sanki (7634) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
22 Jul, 2026Executive summary
Revenue for the nine months ended December 31, 2025, was ¥11,320 million, up 3.2% year-over-year.
Operating income decreased by 2.8% to ¥1,333 million, and ordinary income fell 1.9% to ¥1,402 million year-over-year.
Net income attributable to shareholders was ¥948 million, down 1.7% year-over-year.
The company prioritized stable supply of products/services and safety for stakeholders amid a challenging economic environment.
Financial highlights
Gross profit for the period was ¥5,665 million, with a gross margin of approximately 50%.
Comprehensive income rose 7.0% year-over-year to ¥1,133 million.
EPS for the period was ¥303.68, compared to ¥309.28 in the prior year.
Total assets increased to ¥25,771 million, and net assets to ¥19,599 million.
Outlook and guidance
Full-year revenue forecast remains unchanged at ¥15,260 million, up 4.4% year-over-year.
Operating income is projected at ¥2,140 million (+3.7%), and net income at ¥1,476 million (+0.9%).
Full-year EPS forecast is ¥472.57.
Latest events from Hoshi Iryo-Sanki
- Revenue rose 7.7% but profits fell over 20% year-over-year; guidance unchanged.7634
Q1 202522 Jul 2026 - Modest profit growth and stable outlook, with a completed subsidiary merger for efficiency.7634
Q2 202522 Jul 2026 - Revenue up 3.1% year-over-year, but profits dipped; outlook and dividend unchanged.7634
Q3 202522 Jul 2026 - Modest profit growth driven by home healthcare and medical gas, with stable outlook ahead.7634
Q4 202522 Jul 2026 - Revenue up 1.2% year-over-year, operating profit down 1.9%, dividend forecast raised.7634
Q2 202622 Jul 2026 - Q1 FY2026 delivered strong profit growth and margin expansion, led by medical gas and home healthcare.7634
Q1 202622 Jul 2026 - Revenue up, profits down; home healthcare strong, outlook modestly positive.7634
Q4 202622 Jul 2026